Oxygenta Pharmaceutical Limited (BOM:524636)
India
· Delayed Price · Currency is INR 49.86
-0.74 (-1.46%)
At close: Mar 9, 2026
Oxygenta Pharmaceutical Revenue
Oxygenta Pharmaceutical had revenue of 339.31M INR in the quarter ending December 31, 2025, with 2.18% growth. This brings the company's revenue in the last twelve months to 1.13B, up 60.31% year-over-year. In the fiscal year ending March 31, 2025, Oxygenta Pharmaceutical had annual revenue of 1.09B with 175.71% growth.
Revenue (ttm)
1.13B
Revenue Growth
+60.31%
P/S Ratio
1.63
Revenue / Employee
6.45M
Employees
175
Market Cap
1.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.09B | 696.57M | 175.71% |
| Mar 31, 2024 | 396.42M | 86.55M | 27.93% |
| Mar 31, 2023 | 309.87M | -295.37M | -48.80% |
| Mar 31, 2022 | 605.25M | 84.98M | 16.33% |
| Mar 31, 2021 | 520.27M | 383.01M | 279.03% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambalal Sarabhai Enterprises | 2.03B |
| Astonea Labs | 1.17B |
| Sanjivani Paranteral | 736.34M |
| BDH Industries | 847.44M |
| Coral Laboratories | 875.55M |
| Aayush Wellness | 1.29B |
| Parnax Lab | 2.28B |
| Bilcare | 7.40B |